ENDRA Life Sciences Inc.
NDRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,508 | -$10,060 | -$13,179 | -$11,231 |
| Dep. & Amort. | $206 | $275 | $234 | $224 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $572 | $996 | $1,200 | $1,445 |
| Change in WC | $134 | -$923 | -$1,026 | -$1,261 |
| Other Non-Cash | $3,195 | $163 | $1 | -$299 |
| Operating Cash Flow | -$7,401 | -$9,549 | -$12,769 | -$11,122 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16 | -$34 | -$203 | -$45 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3 | $9 | $0 | $0 |
| Investing Cash Flow | -$13 | -$25 | -$203 | -$45 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$28 | $0 | $0 | $0 |
| Stock Issued | $1,148 | $6,483 | $8,400 | $10,616 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$5 | -$1 | -$8 | -$121 |
| Other Fin. Act. | $0 | $1,036 | $0 | $2,907 |
| Financing Cash Flow | $7,809 | $7,518 | $8,400 | $13,402 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $396 | -$2,055 | -$4,572 | $2,234 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,834 | $4,889 | $9,462 | $7,227 |
| End Cash | $3,229 | $2,834 | $4,889 | $9,462 |
| Free Cash Flow | -$7,417 | -$9,583 | -$12,972 | -$11,167 |